Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

SUIT-015 O2 pti D043

From Bioblast
Revision as of 17:32, 4 February 2019 by Iglesias-Gonzalez Javier (talk | contribs) (Created page with "{{MitoPedia |application=O2 |description=300px |info='''A''' pti: permeabilized tissue- '''SUIT-015''' |abbr=FNS(Oct,PGM) |SUIT num...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)


high-resolution terminology - matching measurements at high-resolution


SUIT-015 O2 pti D043

Description

1OctM;2D;3G;4P;5S;6U;7Rot-.png

Abbreviation: FNS(Oct,PGM)

Reference: A pti: permeabilized tissue- SUIT-015

SUIT number: D042_1OctM;2D;3G;4P;5S;6U;7Rot;8Ama

O2k-Application: O2

SUIT-category: FNS(Oct,PGM)
SUIT protocol pattern: diametral 1OctM;2D;3G;4P;5S;6U:7Rot-

References

Template:SUIT-015 O2 pti D042

Strengths and limitations

+ The protocol provides information on FAO capacity in the absence of other, potentially interfering pathways, both in the LEAK state and in OXPHOS.
+ FNS OXPHOS capacity comprises the most important pathways in many cell types and thus provides a physiologically relevant estimate of maximum mitochondrial respiratory capacity.
+ FNS ET capacity is a good estimate of overall ET capacity in many cell types.
+ The presence of PMG and S establishes a fully operative TCA cycle activity.
+ Application of the cytochrome c test early in the protocol ensures comparability of all states in case of any effect of c.
+ Reasonable duration of the experiment.
- F OXPHOS capacity may be underestimated. In human heart muscle addition of Oct to palmitoylcarnitine (Pal) + malate increased OXPHOS by 26% (Lemuieux et al 2011).
- SRot(E) may be underestimated if S is not saturating.
- CIV activity is not measured, to save experimental time.

Compare SUIT protocols


MitoPedia concepts: SUIT protocol, SUIT A, Find 


MitoPedia methods: Respirometry